madman
Super Moderator
Assessing the Efficacy of Intraurethral Bimix Gel as an Adjunct Therapy in 55 Erectile Dysfunction Patients
Cruz, J1; Farias, A2; Defauwes, N2; Prabhakar, P2; Martinez, D2; Caso, J3
1 - Miami Cancer Institute, Baptist Health South Florida
2 - Miami Cancer Institute
3 - Tulane University
Introduction
Erectile dysfunction can affect men from ages 40 to 70, with a range of 30% to 50% of the population experiencing this inability to achieve and sustain an erection (1). Erectile dysfunction can have a myriad of problems with risk factors such as obesity, smoking, and age, to name a few. The traditional treatments for ED are oral therapy, injections, and penile prostheses, but in some cases, these may not be effective.
Objective
To evaluate the effectiveness of intraurethral Bimix gel as an adjunct to therapy in 56 patients diagnosed with ED.
Methods
A retrospective chart review of patients who were prescribed intraurethral Bimix gel for a diagnosis of ED as an adjunct following primary therapy were selected. This yielded a total of 55 patients with a mean age of 61 (range, 25-85) years. The patients were prescribed intraurethral Bimix gel because of their unsatisfactory response to oral therapy. The efficacy of the gel was evaluated by comparing the Sexual Health Inventory for Men (SHIM) scores before and after the treatment with a Wilcoxon signed rank test.
Results
The mean SHIM score prior to intraurethral Bimix gel was 9.62 (range, 0-24), and following the Bimix gel administration was 11.93 (range, 1-25) (p<0.001). The patients had a favorable response to the intraurethral Bimix gel therapy. This therapy offers a good alternative to patients and an easier mode of administration for patients who are wary of intracavernosal injections. One of the common side effects reported was a mild burning sensation at the administration site during the application and absorption period. There were no other adverse effects.
Conclusions
Intraurethral Bimix gel is a good alternative adjunct to primary oral therapy for erectile dysfunction which can be used together with the initial therapy or as a booster during the act of sexual intercourse as a salvage option. References 1. Khera, M., & Goldstein, I. (2011). Erectile dysfunction. BMJ Clinical evidence, 2011.
Disclosure
No
Cruz, J1; Farias, A2; Defauwes, N2; Prabhakar, P2; Martinez, D2; Caso, J3
1 - Miami Cancer Institute, Baptist Health South Florida
2 - Miami Cancer Institute
3 - Tulane University
Introduction
Erectile dysfunction can affect men from ages 40 to 70, with a range of 30% to 50% of the population experiencing this inability to achieve and sustain an erection (1). Erectile dysfunction can have a myriad of problems with risk factors such as obesity, smoking, and age, to name a few. The traditional treatments for ED are oral therapy, injections, and penile prostheses, but in some cases, these may not be effective.
Objective
To evaluate the effectiveness of intraurethral Bimix gel as an adjunct to therapy in 56 patients diagnosed with ED.
Methods
A retrospective chart review of patients who were prescribed intraurethral Bimix gel for a diagnosis of ED as an adjunct following primary therapy were selected. This yielded a total of 55 patients with a mean age of 61 (range, 25-85) years. The patients were prescribed intraurethral Bimix gel because of their unsatisfactory response to oral therapy. The efficacy of the gel was evaluated by comparing the Sexual Health Inventory for Men (SHIM) scores before and after the treatment with a Wilcoxon signed rank test.
Results
The mean SHIM score prior to intraurethral Bimix gel was 9.62 (range, 0-24), and following the Bimix gel administration was 11.93 (range, 1-25) (p<0.001). The patients had a favorable response to the intraurethral Bimix gel therapy. This therapy offers a good alternative to patients and an easier mode of administration for patients who are wary of intracavernosal injections. One of the common side effects reported was a mild burning sensation at the administration site during the application and absorption period. There were no other adverse effects.
Conclusions
Intraurethral Bimix gel is a good alternative adjunct to primary oral therapy for erectile dysfunction which can be used together with the initial therapy or as a booster during the act of sexual intercourse as a salvage option. References 1. Khera, M., & Goldstein, I. (2011). Erectile dysfunction. BMJ Clinical evidence, 2011.
Disclosure
No
